Gradually implemented new biomarkers for prognostication of breast cancer: Complete case analysis may introduce bias

Journal of Clinical Epidemiology

Volumn 65, Issue 5, 2012, Pages 568-571

  Pathy, Nirmala Bhoo ^a,b,c   Uiterwaal, Cuno S P M ^b   Taib, Nur Aishah ^a   Verkooijen, Helena M ^b,d   Yip, Cheng Har ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c HOSPITAL KUALA LUMPUR   (Malaysia)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Biomarker; Breast cancer; Cancer registry; Complete case analysis; Prognosis; Selection

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL DECISION MAKING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; PRIORITY JOURNAL; BREAST TUMOR; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; PATIENT SELECTION; PROGNOSIS; REGISTER; STATISTICAL MODEL; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; MALAYSIA; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; RECEPTOR, ERBB-2; REGISTRIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84861181410     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2011.09.013     Document Type: Article

References (12)

1. Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer 2010;17:R245-62.
2. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple negative phenotype. A population based study from the California Cancer Registry. Cancer 2007;109:1721-8.
3. Yin WJ, Lu JS, Di GH, Lin YP, Zhou LH, Liu GY, et al. Clinicopath-ological features of the triple-negative tumors in Chinese breast cancer patients. Breast Cancer Res Treat 2009;115:325-33.
4. Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER/PR and Her2 expression: Comparison of clinicopathologic features and survival. Clin Med Res 2009;7:4-13.
5. Bessonova L, Taylor TH, Mehta RS, Zell JA, Anton-Culver H. Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer. Cancer Epidemiol Biomarkers Prev 2011;20:1-8.
6. Lee JA, Kim KI, Bae JW, Jung YH, An H, Lee ES, et al. Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival. Breast Cancer Res Treat 2010;123:177-87.
7. Bhoo Pathy N, Verkooijen HM, Taib NA, Saxena N, Iau P, Bulgiba AM, et al. Association between ethnicity and survival after breast cancer in a multi-ethnic Asian setting: Results from the Singapore-Malaysia hospital-based Breast Cancer Registry. Cancer Res 2010;70(suppl):289s (abstr P3-13-03).
8. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Veen G, et al. Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population. Eur Heart J 2011;32:1926-34.
9. Spijker J, de Graaf R, Ormel J, Nolen WA, Grobbee DE, Burger H, et al. The persistence of depression score. Acta Psychiatr Scand 2006;114:411-6.
10. Ali AM, Dawson SJ, Blows FM, Provenzano E, Ellis IO, Baglietto L, et al. Comparison of methods for handling missing data on immuno-histochemical markers in survival analysis of breast cancer. Br J Cancer 2011;104:693-9.
11. Janssen KJ, Donders AR, Harrell FE Jr, Vergouwe Y, Chen Q, Grobbee DE, et al. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol 2010;63:721-7.
12. Knol MJ, Janssen KJ, Donders AR, Egberts AC, Heerdink ER, Grobbee DE, et al. Unpredictable bias when using the missing indicator method or complete case analysis for missing confounder values: an empirical example. J Clin Epidemiol 2010;63:728-36.